Latest American Society of Clinical Oncology Stories
SAN DIEGO, June 3, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and
As targeted therapies become more available, increasing opportunity exists to match treatments to the genetics of a specific cancer.
- Ceritinib achieved overall response rate of 58.5%, with a median progression-free survival of 8.2 months1 EAST HANOVER, N.J., June 2, 2014 /PRNewswire/ -- Novartis today announced data showing
New Study Shows Oncotype DX® DCIS Score(TM) Changes Treatment Recommendations for One Out of Three DCIS Patients REDWOOD CITY, Calif., June 1, 2014 /PRNewswire/ -- Genomic Health, Inc.
Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/
Leslie Robison, Ph.D., becomes the fifth researcher from St. Jude Children’s Research Hospital to receive the Pediatric Oncology Award Memphis, Tenn.
NEW YORK, May 30, 2014 /PRNewswire/ -- MedPage Today, a property of Everyday Health, Inc.
Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes
THOUSAND OAKS, Calif., May 29, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will hold a post-American Society of Clinical Oncology (ASCO) summary webcast on Tuesday, June
Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys Shared with 10-City Hope Murals Project CHICAGO, May 29, 2014 /PRNewswire/ -- The American Society of Clinical Oncology's
- totally perplexed and mixed up.